Apatinib Mesylate Combined with Etoposide in the Treatment of Platinum Resistant Recurrent Ovarian Cancer: A Report of Two Cases
GUO Yi-lin
WANG Wu-liang
Machine-generated Keywords：
Publication Date：2022-08-15
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：4( 411-414 )